EU GDP for Medicinal Products: The Responsible Person and Training Duties

Good Distribution Practice is the part of pharmaceutical quality regulation that puts training in the text rather than leaving it to inference. The EU guidelines (2013/C 343/01) open Chapter 2 with the observation that correct distribution of medicinal products "relies upon people," and then set out what those people must know before they touch stock. For a wholesale distributor, a broker or a logistics provider, this is the clearest competence mandate in the regulatory estate.

What GDP covers

The guidelines run to eleven chapters: quality management, personnel, premises and equipment, documentation, operations, complaints and returns and recalls, outsourced activities, self-inspections, transportation, specific provisions for brokers, and final provisions. Two features shape everything else. The quality system is explicitly risk-based, with effort proportional to risk and a reference to ICH Q9. And the whole framework is built around preventing falsified medicines from entering the legitimate supply chain, which is why supplier and customer qualification carry so much weight.

The Responsible Person

Every wholesale distributor must designate a Responsible Person, and the role is personal. The guidelines require them to meet the qualifications and conditions set by their Member State’s legislation, state that a degree in pharmacy is desirable, and expect relevant competence, experience and GDP knowledge and training alongside it. The post holder must act personally and remain contactable, and — the sentence that defines the job — may "delegate duties but not responsibilities."

A written job description must define their decision-making authority, and the company must actually provide the authority, resources and responsibility the role needs. Their twelve listed duties include maintaining the quality management system, managing authorised activities and record accuracy, overseeing training programmes, coordinating and promptly performing recalls, handling complaints, approving suppliers and customers, approving subcontracted activities, arranging self-inspections, and deciding the disposition of returned, rejected, recalled or falsified products.

That list is worth reading as a competence specification rather than a list of tasks. A Responsible Person who cannot personally judge whether a supplier is acceptable, whether a return may go back to saleable stock, or whether a self-inspection finding is adequately closed is not equipped for the appointment, however senior.

The training requirements, stated plainly

Section 2.4 is unusually specific for a guideline of this kind. All personnel involved in wholesale distribution must be trained on GDP requirements before starting their tasks, not within a reasonable period after. Training must be both initial and continuing, based on written procedures and a written programme, and the Responsible Person must keep their own GDP competence current through regular training.

Content is prescribed in two directions. Training must cover product identification and avoiding falsified medicines entering the supply chain — the universal element. And staff handling products with stricter requirements need specific training for those products: the guidelines name hazardous materials, radioactive materials, products presenting special risks of abuse including narcotics and psychotropic substances, and temperature-sensitive products.

Records must be kept, and this is where firms most often fall short: training effectiveness must be assessed and documented periodically. Attendance is not evidence of effectiveness. An inspector asking how a distributor knows its falsified-medicines training worked is asking a question the guidelines require an answer to.

The controls that training has to support

Several GDP obligations only function if the people executing them have been taught to recognise a problem. Supplier due diligence under section 5.2 requires attention to the reliability of the supplier, offers of products more likely to be falsified, unusually large offers of products in limited supply, and prices outside the expected range. Customer qualification under 5.3 requires unusual sales patterns of narcotics or psychotropic substances to be investigated and, where necessary, reported. Both are judgement calls made by staff, at speed, against commercial pressure.

Returns are the same. Section 6.3 allows return to saleable stock only under strict conditions: unopened and undamaged packaging, proof of original supply, no reason to suspect falsification, and documented evidence of temperature compliance for temperature-sensitive products. Recovered stolen products may not be resold at all. Suspected falsified products must be segregated and the competent authority and marketing authorisation holder informed immediately.

Storage and distribution controls lean on the same competence: first expiry first out, regular stock inventories, temperature mapping of storage areas before use and after significant change, monitoring equipment calibrated to traceable standards with alarms tested regularly, and transport temperature monitoring equipment calibrated at least annually. Records must be retained for the period set by national law and in any case at least five years.

Computerised systems and outsourcing

Section 3.3.1 requires computerised systems to be validated, documented in up-to-date detail, protected against unauthorised change, backed up, and retained for at least five years at a secure separate location. The discipline is recognisably the same one applied to manufacturing systems — see our guide to computer system validation under Annex 11 for how that validation logic is constructed.

Chapter 7 keeps responsibility with the contract giver. Outsourced activities need a written contract defining duties, the giver must assess the acceptor’s competence and audit them before work starts and after changes, audit frequency is risk-based, and the acceptor may not subcontract without prior approval. Outsourcing distribution does not outsource the obligation, which matters in a sector where third-party logistics is the norm.

Brokers are in scope too

Chapter 10 catches brokers who negotiate sales or purchases without ever physically handling product. They must register and maintain a permanent address in their Member State, and while the premises and equipment requirements do not apply, most of the rest does: a quality system, staff training, an emergency recall plan, transaction records, and procedures for complaints, falsified medicines reporting, recalls and supplier and customer verification. A business model built on not touching the goods does not escape the training requirement.

Building the competence

GDP training sits awkwardly in most organisations because it spans warehouse operatives, transport planners, quality staff and the Responsible Person, who need the same framework at very different depths. The documentation, quality management and audit disciplines underneath it are common to the wider regulated environment, including the batch record review and certification process upstream. Our CPD course library covers those quality and audit foundations.

Frequently asked questions

Does the Responsible Person have to be a pharmacist?

Not necessarily. The guidelines say a degree in pharmacy is desirable and require the person to meet the qualifications and conditions laid down by the legislation of the Member State concerned — so the binding answer is national, and some Member States are stricter than the guideline.

When must GDP training be completed?

Before the person starts their tasks. Section 2.4 requires training on GDP requirements prior to commencing duties, with continuing training thereafter under a written programme.

Is keeping attendance records enough?

No. Records must be kept, and in addition the effectiveness of training must be assessed and documented periodically. Those are two separate obligations.

Do third-party logistics providers need their own GDP training?

Yes, and the contract giver has to satisfy itself that they do. Chapter 7 requires the contract giver to assess the competence of the contract acceptor and to audit them before activities start and after any changes, with responsibility remaining with the giver throughout.